Biotech Stocks

2 Notable Biotech Calls

It has not been a good day for investors this Thursday.  Worries about trade, the situation in Saudi Arabia, plunging oil prices, falling …

H.C. Wainwright Reiterates Upbeat View of EyePoint Pharmaceuticals (EYPT) Stock on Back of FDA Approval

EyePoint Pharmaceuticals (EYPT) has a big reason to celebrate this week — the Food and Drug Administration (FDA) approved the vision-improving technology. The fluocinolone …

Oppenheimer Pounds the Table on Catalyst Pharmaceuticals (CPRX) Ahead of Upcoming FDA Decision

Oppenheimer analyst Leland Gershell was out pounding the table on shares of Catalyst Pharmaceuticals (CPRX), reiterating a Buy rating and price target of $6.00, which implies …

This Analyst Presses the ‘Buy’ Button on Vascular Biogenics (VBLT) Stock; Here’s Why

It’s one small step forward for Vascular Biogenics (VBLT), one giant leap for the company’s stock rating. H.

This Analyst Cheers for AcelRx (ACRX), the Little Opioid Company that Could

Drug company AcelRx (ACRX) is likely celebrating its first win after getting news from the Food and Drug Administration (FDA) late Friday afternoon …

4 Notable Analyst Calls in the Biotech Sector: Loxo Oncology (LOXO), VBL Therapeutics (VBLT), Kalvista Pharmaceuticals (KALV), Aimmune (AIMT)

Investors have been treated like rented mules by the market so far here in October.  More than 75% of the S&P 500 (including …

AcelRx (ACRX) Stock Wins Another Price Target Hike Following Promising News on the Regulatory Front

Investors are jumping in and out ahead of a Food and Drug Administration (FDA) decision on AcelRx’s (ACRX) opioid pain drug Dsuvia, with …

Acelrx (ACRX) Stock Is Firing on All Cylinders; Cantor Boosts Price Target

Acelrx’s (ACRX) shares popped over 20% in pre-market trading Monday, following indications that the U.S.

Trevena (TRVN): The AdCom Vote Was a Lot Closer Than You Think

Some investors might love biotech stocks for their lottery ticket-like returns when a company wins the regulator’s blessing. A lottery ticket, however, costs only …

Trevena (TRVN) Stock Hit with a Downgrade; Shares Tumble Over 10%

In a research note issued today, healthcare analyst Alan Carr of Needham walks investors through this week’s Trevena (TRVN) bloodbath. Shares are down nearly over …